Harvey Capital Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-61,626
| Closed | -$6.12M | – | 81 |
|
|
2019
Q3 | $6.12M | Sell |
61,626
-300
| -0.5% | -$28.5K | 3.04% | 8 |
|
|
2019
Q2 | $5.72M | Sell |
61,926
-301
| -0.5% | -$28.6K | 2.75% | 11 |
|
|
2019
Q1 | $5.87M | Sell |
62,227
-19,120
| -24% | -$1.67M | 2.82% | 11 |
|
|
2018
Q4 | $5.21M | Buy |
81,347
+7,067
| +10% | +$522K | 2.77% | 11 |
|
|
2018
Q3 | $6.65M | Buy |
74,280
+400
| +0.5% | +$35.3K | 2.65% | 12 |
|
|
2018
Q2 | $5.87M | Sell |
73,880
-400
| -0.5% | -$33.2K | 2.33% | 15 |
|
|
2018
Q1 | $6.63M | Buy |
74,280
+1,025
| +1% | +$98.4K | 2.48% | 13 |
|
|
2017
Q4 | $7.64M | Buy |
73,255
+7,955
| +12% | +$898K | 2.77% | 10 |
|
|
2017
Q3 | $9.52M | Sell |
65,300
-125
| -0.2% | -$17K | 3.84% | 4 |
|
|
2017
Q2 | $8.5M | Buy |
65,425
+425
| +0.7% | +$52.1K | 3.64% | 6 |
|
|
2017
Q1 | $8.09M | Buy |
65,000
+620
| +1% | +$74.2K | 3.63% | 7 |
|
|
2016
Q4 | $7.45M | Sell |
64,380
-725
| -1% | -$80.7K | 3.47% | 7 |
|
|
2016
Q3 | $6.8M | Buy |
65,105
+805
| +1% | +$87.1K | 2.1% | 12 |
|
|
2016
Q2 | $6.34M | Sell |
64,300
-12,250
| -16% | -$1.27M | 3.18% | 11 |
|
|
2016
Q1 | $7.66M | Sell |
76,550
-2,400
| -3% | -$247K | 3.71% | 9 |
|
|
2015
Q4 | $9.46M | Sell |
78,950
-31,975
| -29% | -$3.7M | 3.73% | 6 |
|
|
2015
Q3 | $12M | Sell |
110,925
-26,225
| -19% | -$3.25M | 4.79% | 5 |
|
|
2015
Q2 | $16.4M | Sell |
137,150
-9,850
| -7% | -$1.13M | 5.55% | 3 |
|
|
2015
Q1 | $16.9M | Sell |
147,000
-3,100
| -2% | -$370K | 6.23% | 2 |
|
|
2014
Q4 | $16.8M | Sell |
150,100
-4,400
| -3% | -$464K | 6.44% | 3 |
|
|
2014
Q3 | $14.6M | Sell |
154,500
-500
| -0.3% | -$45.1K | 5.74% | 3 |
|
|
2014
Q2 | $13.3M | Buy |
155,000
+29,100
| +23% | +$2.21M | 4.76% | 5 |
|
|
2014
Q1 | $8.79M | Sell |
125,900
-10,000
| -7% | -$792K | 3.5% | 10 |
|
|
2013
Q4 | $11.5M | Sell |
135,900
-2,000
| -1% | -$158K | 4.74% | 7 |
|
|
2013
Q3 | $10.6M | Sell |
137,900
-24,900
| -15% | -$1.74M | 5.4% | 4 |
|
|
2013
Q2 | $9.52M | Buy |
+162,800
| New | +$9.8M | 5.91% | 1 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Harvey Capital Management's CELG Position: Q4 2019 in Review
Harvey Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 61,626 shares — an estimated $6.12M sold.
Harvey Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $16.9M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Harvey Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Harvey Capital Management sold 61,626 Celgene Corp shares in Q4 2019, an estimated $6.12M.
- Harvey Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Harvey Capital Management's Celgene Corp position peaked at $16.9M in Q1 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Harvey Capital Management's 13F filing for Q4 2019, filed 4 Feb 2020.